Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter

被引:88
作者
Wu, J
Ohta, Y
Minato, H
Tsunezuka, Y
Oda, M
Watanabe, Y
Watanabe, G
机构
[1] Kanazawa Univ, Sch Med, Dept Surg 1, Kanazawa, Ishikawa 9208641, Japan
[2] Kanazawa Univ, Sch Med, Dept Pathol, Kanazawa, Ishikawa 9208641, Japan
[3] Kanazawa Med Coll, Dept Thorac Surg, Kanazawa, Ishikawa, Japan
关键词
D O I
10.1016/S0003-4975(01)02520-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Detection of occult micrometastasis in regional lymph nodes is crucial for diagnosis and selection of appropriate therapy for patients with pN0 nonsmall-cell lung carcinoma. Using immunohistochemical staining, we evaluated the impact of detection of occult micrometastasis on the prevalence and prognosis of patients with lung adenocarcinoma of 2.0 cm or less in diameter. Methods. A total of 103 pN0 disease patients with peripheral lung adenocarcinomas of 2.0 cm or less in diameter were enrolled in this study: We studied 1,438 regional lymph nodes for occult micrometastasis by immunohistochemical staining for cytokeratins. Results. Micrometastasis was detected in 49 lymph nodes (3.4%) of 21 patients (20.4%) but not in patients with localized bronchioloalveolar carcinoma or localized bronchioloalveolar carcinoma with foci of collapse of alveolar structure. The 5-year survival rate (61.9%) of patients with micrometastasis was significantly (p 0.0041) lower than that of patients without micrometastasis (86.3%). Conclusions. There still remains a risk of nodal micrometastasis in patients with primary peripheral lung adenocarcinoma, even if the diameter of the tumor is smaller than 2.0 cm. Selection of patients for limited surgery should be done prudently, talking into consideration the risk of nodal micrometastasis.
引用
收藏
页码:1772 / 1777
页数:6
相关论文
共 27 条
[1]  
[Anonymous], GEN RUL CLIN PATH RE
[2]   FREQUENCY AND DISTRIBUTION OF OCCULT MICROMETASTASES IN LYMPH-NODES OF PATIENTS WITH NON-SMALL-CELL LUNG-CARCINOMA [J].
CHEN, ZL ;
PEREZ, S ;
HOLMES, EC ;
WANG, HJ ;
COULSON, WF ;
WEN, DR ;
COCHRAN, AJ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (06) :493-498
[3]  
Czerniecki BJ, 1999, CANCER, V85, P1098, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1098::AID-CNCR13>3.3.CO
[4]  
2-E
[5]   Micrometastatic p53-positive cells in the lymph nodes of non-small-cell lung cancer: Prognostic significance [J].
Dobashi, K ;
Sugio, K ;
Osaki, T ;
Oka, T ;
Yasumoto, K .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 114 (03) :339-346
[6]   COMPARISON OF COMMERCIALLY AVAILABLE CYTOKERATIN ANTIBODIES IN NORMAL AND NEOPLASTIC ADULT EPITHELIAL AND NONEPITHELIAL TISSUES [J].
GODDARD, MJ ;
WILSON, B ;
GRANT, JW .
JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (08) :660-663
[7]  
GREENSON JK, 1994, CANCER-AM CANCER SOC, V73, P563, DOI 10.1002/1097-0142(19940201)73:3<563::AID-CNCR2820730311>3.0.CO
[8]  
2-D
[9]   STRATEGY FOR LYMPHADENECTOMY IN LUNG-CANCER 3 CENTIMETERS OR LESS IN DIAMETER [J].
ISHIDA, T ;
YANO, T ;
MAEDA, K ;
KANEKO, S ;
TATEISHI, M ;
SUGIMACHI, K .
ANNALS OF THORACIC SURGERY, 1990, 50 (05) :708-713
[10]   Clinical analysis of small-sized peripheral lung cancer [J].
Koike, T ;
Terashima, M ;
Takizawa, T ;
Watanabe, T ;
Kurita, Y ;
Yokoyama, A .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 115 (05) :1015-1020